Onesource Specialty Pharma Limited Stock: price and insider trades · India

Onesource Specialty Pharma Limited belongs to the Health Care sector. Filings by its managers are published through SEBI (PIT + SAST). Over the twelve months to 8 November 2026, 6 filings were filed, from 3 insiders.

Not one open-market sale was filed. On the buying side, 3 insiders reported 6 purchases totalling €4.1M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Among those who bought: 3 major shareholders. The largest single trade was a purchase of €2.2M by Tenshi Pharmaceuticals Private Limited, published on 4 February 2026.

Within a 30-day window, 5 purchases overlapped with buying by a second insider. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The latest purchase dates back some time: it was published 277 days ago, on 4 February 2026. Typically, a trade is published a median of 2 days after it takes place. Until a filing is published, the market cannot know about the trade.

For context, the typical company on the same exchange (median of 1,985 companies) published 4 filings over the same period, against 6 filings here. Since 2025, the database holds 6 purchases and 10 sales by insiders of the company.

For comparison within the same sector, see the insider buying recorded at MAIA Biotechnology, Inc. and Cooper Companies, Inc. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.